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DISPARITIES IN FOLLOW-UP ADHERENCE AMONGST PEDIATRIC  
 
PATIENTS WITH CELIAC DISEASE 
 
BRADLEY A. BLANSKY 
 
ABSTRACT 
Introduction:  
Celiac disease is a chronic immune disorder for which the only treatment is strict lifelong 
adherence to a gluten-free diet (GFD).  Collaborative management through regular fol-
low-up with a care team that includes physicians and dietitians may improve long-term 
outcomes. However, many individuals with celiac disease are lost to follow-up.  
Objective: 
This primary objective of this study was to identify factors associated with pediatric ce-
liac disease patients being lost to follow-up. Secondary aims included identifying adher-
ence to recommended care practices by both patients and providers. 
Methods: 
A chart review of 250 randomly selected children with biopsy-confirmed celiac disease 
diagnosed between 2010 and 2014 at Boston Children’s Hospital (BCH) was conducted. 
Follow-up records were reviewed from diagnosis to 2017. Eligible children were diag-
nosed prior to age 18 and did not attend BCH solely for a second opinion. Demographics, 
medical history, visit information, and lab results were collected using an online data-
base.  
Results:   
 vi 
Of the 241 eligible subjects (64% female, 1-17 years, median 9.7 years) the median time 
until lost to follow-up was 2.8 years from diagnosis (IQR, 1.0-4.7 years) with 22 subjects 
(9%) not attending any follow-up visits with their pediatric gastroenterologist (GI) after 
diagnosis and an additional 37 subjects (14%) lost within the first year. A majority of 
subjects (83%) attended a GFD education visit with a registered dietitian, although this 
was not associated with follow-up adherence (P>0.5). Excluding those who had aged out 
of the clinical practice, children who were adherent to follow-up had a younger mean age 
of diagnosis (95% CI 0.5-3.1, P<0.01). Children who were insured under Medicaid/CHIP 
(N=20) were more likely to be lost within one year compared to those with private health 
insurance (P<0.01). Celiac serologies taken at time of last clinical visit were abnormal in 
25% of the subjects with available results (N=141) and the median time since diagnosis 
in this positive serology subgroup was 20 months (IQR, 12-29 months).   
Discussion: 
The present study illustrates that children with celiac disease are not being followed-up 
adequately and that identifiable disparities exist in the pediatric celiac disease population. 
Within three years of diagnosis, 50% of the cohort was lost to follow-up with the major-
ity of subjects lost within the first year of diagnosis. Children diagnosed at a younger age 
were more adherent to follow-up compared to those diagnosed during adolescence. Fac-
tors associated with decreased adherence included reliance on public medical insurance 
and older age at diagnosis. Improvement in long-term management of celiac disease may 
be achieved by increased outreach and education. 
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 1 
INTRODUCTION 
 Celiac disease is a chronic gastrointestinal disorder that can present with a wide 
range of intestinal and extra-intestinal symptoms due to an immune reaction triggered by 
ingestion of gluten.1 This disease affects approximately 1% of the global population with 
an increased prevalence among individuals with a family history of celiac disease and 
those with comorbidities such as trisomy 21, type I diabetes mellitus or other autoim-
mune disorders.2,3 Females are slightly more likely to be diagnosed with celiac disease 
and most children are diagnosed between the ages of 7 and 10 years old.4 The treatment 
of celiac disease requires strict lifelong adherence to a gluten-free diet, passing the onus 
of care from the healthcare provider to the patient.1 Due to the communal role food plays 
in many cultures, individuals with celiac disease often report initial difficulty following a 
gluten-free diet and may have persisting symptoms due to non-adherence.5 To help ease 
the treatment burden, as well as assure adequate mucosal recovery, national and interna-
tional guidelines recommend that healthcare providers provide routine follow-up care to 
patients with celiac disease to monitor their health and assist with dietary management. 6–
8 However, attendance follow-up visits is inconsistent, which may result in poor disease 
management along with decreased quality of life for these individuals.9 The purpose of 
this study is to identify factors associated with non-adherence to follow-up in children 
with celiac disease. 
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Overview and Diagnosis of Celiac Disease 
Celiac disease is an immune-mediated enteropathy that is activated by exposure to 
gluten. Gluten refers to both the specific plant storage protein found in wheat as well as 
an umbrella term for storage proteins in other cereal grains such as barley and rye. Gluten 
is composed of two main proteins, glutenin and gliadin, which are rich in proline and glu-
tamine residues forming short, compact peptide chains that are difficult for digestive pro-
teases to breakdown. Due to their proline rich nature, these proteins are also called prola-
mins.10 
Gluten contains a wide variety of immunogenic epitopes, with the most common 
being contained within a 33-amino acid sequence in α-gliadin. The α-gliadin and other 
peptides are deamidated by the endogenous enzyme tissue transglutaminase (tTG), form-
ing a negatively charged peptide. These modified gliadin peptides elicit an immune re-
sponse due to an increased affinity to the major histocompatibility complex (MHC) II of 
antigen presenting cells encoded by the human leukocyte antigen (HLA) serotype DQ2 
and DQ8, present in individuals with celiac disease.11 Mucosal injury occurs as a result of 
the release of pro-inflammatory cytokines, such as interferon-γ and interleukin-21, and 
infiltration of cytotoxic T-cells in the intestinal epithelium and lamina propria. The auto-
immune component of celiac disease is mediated by the humoral response and results in 
formation of high affinity anti-tTG and other autoantibodies, possibly stimulated by tis-
sue injury. The accumulation of these autoantibodies in the intestinal mucosa and even-
tual overflow into systemic circulation may contribute to systemic manifestations of ce-
liac disease.1,12 
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Individuals with celiac disease may present with a wide range of symptoms, or no 
overt symptoms at all, which can make diagnosis difficult. Classical symptoms are most 
common in those diagnosed in early childhood, often coinciding with the introduction of 
gluten into the child’s diet between ten and twenty-four months of age, and include 
chronic diarrhea, failure to thrive, and abdominal pain or distension.1 In older children, 
diarrhea is less common and symptoms often present as consequences of chronic enterop-
athy and malabsorption, such as iron-deficiency anemia, aphthous stomatitis, and growth 
or pubertal delays.13 Asymptomatic celiac disease is often more difficult to diagnose as 
individuals do not present with outward complaints and this group is most often diag-
nosed due to screening because of other risk factors.13 
Diagnosis of celiac disease is often confirmed through a combination of blood 
tests and biopsies gathered through an esophagogastroduodenoscopy (EGD). If celiac dis-
ease is suspected due to either symptoms or secondary risk factors, initial screening often 
involves serological testing for autoantibodies such as anti-tTG immunoglobulin A (IgA), 
anti-endomysial antibodies (EMA) IgA and total IgA.7 Individuals with celiac disease are 
more likely than the general population to be IgA deficient, thus current guidelines advise 
that in these scenarios immunoglobulin G (IgG) autoantibody testing should be used in-
stead.8  Results for these tests are positively correlated with likelihood of the person hav-
ing celiac disease, and current guidelines of the European Society of Pediatric Gastroen-
terology, Hepatology, and Nutrition state that levels of anti-tTG antibodies over ten times 
the upper limit of normal along with positive anti-EMA antibodies and HLA genotyping 
indicative of celiac disease are often sufficient for a diagnosis in symptomatic 
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individuals.6 However, the European guidelines recommend biopsy for patients with a 
tTG below ten times the upper limit of normal as well as those with an elevated tTG but a 
negative EMA. Diagnostic algorithms published by the British Society of Paediatric Gas-
troenterology, Hepatology and Nutrition and the North American Society of Pediatric 
Gastroenterology, Hepatology and Nutrition require intestinal biopsy to confirm a celiac 
disease diagnosis.7,8 Thus, an overwhelming majority of children are often diagnosed 
with celiac disease on the basis of intestinal biopsy findings. 
Biopsies gathered during EGD procedures are used to identify histological 
changes to the duodenal mucosa of people with celiac disease. Histological findings are 
graded on a six-level Marsh scoring system ranging from 0 to 3c, based on presence of 
intraepithelial lymphocytes, crypt hyperplasia, and villous atrophy.7  
Treatment Through a Gluten-Free Diet: Challenges and Benefits 
  The only currently available treatment for celiac disease is a lifelong strict glu-
ten-free diet (GFD). This diet requires avoiding foods that contain gluten, barley, and rye. 
In practice, strict avoidance of gluten can be difficult as food labels are often inadequate 
or unavailable, for example in restaurants or other social gatherings.14 Obvious sources of 
gluten include breads, pastas, and other baked goods; however, gluten may also be pre-
sent in food thickeners, fillers, or processed meats.10 Oats are also controversial for those 
on a gluten-free diet because while they can be a good source of nutrients that many with 
celiac disease are deficient in, research is conflicting over whether avenin peptides in oats 
can cause an immune response in individuals with celiac disease.15 Cross-contamination 
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during manufacturing and food preparation is also difficult to regulate and thus individu-
als with celiac disease must take extra precaution when buying pre-packaged meals.16  
 Due to the abundance of gluten-containing foods and frequent reliance on pro-
cessed foods, the early stages of transitioning to a GFD may be especially difficult. Initial 
challenges to a GFD include proper identification of prohibited ingredients on food labels 
and an increase in grocery budget and meal preparation time.5 This is especially true in 
the pediatric population, as children are often resistant to trying new foods, reliant on 
adult caretakers to provide food, and may be more susceptible to peer pressure.16 Even 
after initiation of the diet, many adults and children report difficulty maintaining a GFD 
in less controlled environments outside of the household such as at restaurants and while 
traveling resulting in some families avoiding these activities altogether.17  
  Despite these challenges, those who follow a strict GFD generally report positive 
outcomes in regard to their celiac disease symptoms. In a survey of adults with celiac dis-
ease, over half of subjects who had abdominal pain and/or diarrhea at diagnosis had alle-
viation of symptoms after starting the diet.18 The average time for alleviation of symp-
toms in this cohort was approximately four weeks. While improvement of symptoms is 
often an important, maintenance of a GFD also promotes recovery of intestinal damage 
that, if left untreated, could result in poor long-term outcomes such as increased risk for 
intestinal carcinomas, lymphoma, and osteoporosis.19 
 Complete restoration of intestinal villi does not happen simultaneously with alle-
viation of symptoms or normalization of serologies. A retrospective study of those who 
had a follow-up EGD two years after being diagnosed with celiac disease and 
 6 
commencing a GFD showed that less than 50% had complete recovery of intestinal 
villi.19 Factors that were associated with poor recovery from villous atrophy included in-
creased age of diagnosis, lower educational attainment, and the male sex.  
Persistent mucosal damage is often attributed to continual gluten exposure, either 
intentional or accidental. Deliberate non-adherence to a GFD is commonly underreported 
and compliance in children often coincides with parental attitudes towards the GFD.20 
Even individuals who report being on a strict GFD are often found to have persistent vil-
lous atrophy, indicating potential unintentional ingestion of gluten.21 Self-reported adher-
ence to a GFD is often overestimated due to lack of knowledge about sources of gluten in 
everyday food items.22 Adequate education about the GFD has been shown to increase 
both dietary adherence and of intestinal recovery.21 
Adherence to a GFD is important not only for long-term health, but also critical 
for children during the periods of growth and development. Persistent intestinal inflam-
mation can have a significant impact on absorption of micronutrients such as vitamin D 
which is needed for proper bone growth and thus lack of dietary adherence can result in 
disruptions in bone metabolism.23 In many children with celiac disease, low bone mineral 
density can be reversed and return to normal after commencing a strict gluten-free diet.24 
Adequate vitamin D and calcium intake is especially important in pediatric and adoles-
cent populations due to the fact that maximum bone density is achieved between the ages 
of twenty and twenty-five years of age.25 It is also recommended that children enrich 
their diet with calcium and vitamin D, either through foods abundant in these nutrients or 
through vitamin supplements.26 Counseling with a registered dietitian can help properly 
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educate children and their caretakers to make sure that their individual diets contain ade-
quate nutrients for proper growth during these critical times as well as monitoring of 
height, weight, and body mass index.23 
Recent studies have also indicated that individuals with the HLA-DQ2 genotype 
are more likely to be nonresponsive to the hepatitis B vaccination, increasing their risk 
for acquiring this infection.27 However, after commencement of a GFD, individuals with 
celiac disease are more likely to respond to a booster of the hepatitis B vaccine and titers 
should be obtained to assure adequate immunity to the virus.28 
Role of Clinicians and Dietitians in Celiac Disease Management 
 
 While the primary role of treatment of celiac disease is often left to the child and 
their caregivers responsible for medical and dietary decisions, the involvement of clini-
cians and dietitians is also important. Long-term engagement between the patient and 
healthcare provider has been shown to improve long-term management of chronic ill-
nesses.29  
 Continual evaluation of dietary compliance is critical to long-term care of this 
population due to increasing evidence that lack of compliance is correlated with long-
term risk for gastrointestinal complications.30 Celiac related autoantibodies tend to nor-
malize within six to twelve months after commencing a gluten-free diet, which makes it 
less sensitive to intermittent exposure to gluten but a good overall indicator of gluten-free 
diet status.8 Collection of additional intestinal biopsies to check for mucosal recovery af-
ter commencing a gluten-free diet has the disadvantages of being time consuming and 
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invasive for the individuals as well as requiring an expert pathologist to interpret re-
sults.31 Use of dietary evaluation surveys can help identify sources of gluten in people’s 
diet and are becoming a standardized method for assessing dietary adherence.31,32 Meth-
ods to detect gluten immunogenic peptide biomarkers in stool and urine are currently be-
ing developed as a technique to identify recent gluten exposure.33 The presence of gluten 
immunogenic peptides in the urine may be more sensitive means of detecting mucosal 
damage when serological results are negative.34 
 Follow-up care by physicians, nurses, and dietitians is important for the long-term 
success of individuals with celiac disease. Studies have shown that those who are adher-
ent to follow-up visits have higher chances of normalized serologies, increased growth, 
and better psychological wellbeing, especially if these habits are started at a young age 
and continued through adulthood.20,35 Regularly scheduled follow-up visits with a multi-
disciplinary team of healthcare providers helps children and caretakers stay informed 
with accurate information of maintaining a healthy GFD and can decrease the perceived 
treatment burden of celiac disease while increasing overall satisfaction.36  
 The Celiac Disease Program at Boston Children’s Hospital (BCH) has established 
its own set of guidelines for treatment and monitoring of children with celiac disease. 
 The current recommended follow-up schedule for children with newly diagnosed 
celiac disease at BCH includes the following: 
a) Attendance of “Going Gluten-Free” nutritional diet class with registered dietitian 
b) Individual follow-up with dietitian 2 to 3 weeks after the class 
c) Attendance of 3-month follow-up visit with physician 
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d) Attendance of 6-month follow-up visit with physician 
e) Attendance of 12-month follow-up visit with physician 
f) Annual follow-up visits with physician until transfer of care to an adult gastroen-
terologist 
Aims of the Current Study 
 Previous unpublished studies using BCH Patient360 clinical data registry found 
that loss to follow-up of children with celiac disease is a significant problem, with a ma-
jority of patients being lost within five years of diagnosis. We hypothesized that patient 
level data would lead to identification of both modifiable and non-modifiable patient 
characteristics associated with follow-up adherence. Socioeconomic disparities in the 
presentation and management of celiac disease have been previously studied, including 
the underdiagnoses of children from low income homes along with the increased likeli-
hood of persistence of symptoms.37,38 Barriers to accessing clinical appointments due to 
travel constraints have been shown to disproportionally affect families with a lower soci-
oeconomic status and we hypothesized that this would be true for our study.39 Along with 
socioeconomic status, we also sought to evaluate the association between age of diagno-
sis, GFD adherence, and presence of comorbidities with adherence to follow-up with a 
pediatric gastroenterologist for long-term celiac disease management. This information 
may be useful for healthcare providers by indicating that children meeting these criteria 
may be more vulnerable to being lost to follow-up and thus facilitate early intervention to 
reduce the risk for these subpopulations.  
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METHODS  
 
Study Design and Definitions 
 A retrospective chart review was conducted by examining the medical records of 
250 children diagnosed with celiac disease at BCH between January 1st, 2010 and De-
cember 31st, 2014. Subjects were randomly selected from an existing database maintained 
within the Department of Gastroenterology and Nutrition at BCH, which includes chil-
dren diagnosed with biopsy-confirmed celiac disease within the hospital network. Medi-
cal records from BCH were reviewed between January 1st, 2010 and December 31st, 
2017. This time frame allowed for evaluation of follow-up visits for a minimum of three 
years following biopsy diagnosis. Subjects who had reached the age of 18 prior to diag-
nosis were excluded as well as those who came to BCH seeking a second opinion. 
 This study was approved by the Institutional Review Board at BCH. 
For clinical results, low vitamin D was defined as levels below 30ng/mL and up-
per limit of normal for celiac antibody serologies was based on the specific assay used by 
the individual lab. BMI Z-scores were used to classify growth status, with -2.0 being de-
fined as underweight, +1.0 as overweight, and +2.0 as obese.40 Adherence to a GFD was 
determined based on persistence of symptoms, celiac serology, and clinician assessment 
at final follow-up visit. Subjects were then categorized as either adherent or non-adherent 
to the GFD. 
 “Lost to follow-up” was defined as subjects who did not return for a subsequent 
clinical gastroenterology visit with a physician or nurse practitioner, or a nutrition visit 
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with a registered dietitian, at either the main BCH campus or a network satellite clinic af-
ter being diagnosed with celiac disease. Time until lost to follow-up was calculated as the 
interval between the initial endoscopy and the last clinical gastroenterology visit at-
tended. Subjects whose last visit was after the age of 18 were not considered lost as they 
were eligible to continue care with an adult gastroenterologist outside of the BCH net-
work. However, individuals who continued to see their pediatric gastroenterologist be-
yond the age of 18 were not excluded if they continued to be adherent to follow-up. 
A secondary analysis was performed to determine if the loss to follow-up was re-
lated to relocation. This was done by comparing the last celiac disease follow-up visit 
with visit dates with other providers within the BCH network. An attended visit with a 
network provider after the subject was defined as “lost to follow-up” to the gastroenterol-
ogy and nutrition department was used to establish positive residency. 
 Adherence to follow-up was categorized based on the recommended follow-up 
schedule at BCH and previous studies9 
1) Lost to GI follow-up after diagnosis 
a. Did not attend dietitian education 
b. Attended dietitian education 
2) Lost within one year after attending at least one clinician follow-up 
3) Lost to follow-up one year after diagnosis, attended at least one follow-up 
visit within first year 
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4) Non-adherent to recommended follow-up schedule as defined as first follow-
up visit over one year after diagnosis and/or follow-up visits over 18 months 
apart 
5) Adherent to recommended follow-up schedule 
6) Lost to follow-up after age 18 
Data Collection and Measurements 
Study data was collected and managed on a case report form (Appendix 1) created 
using the Research Electronic Data Capture (REDCap) electronic data capture tool hosted 
by BCH. REDCap is a secure, web-based application designed to support data capture for 
research studies, providing 1) an intuitive interface for validated data entry; 2) audit trails 
for tracking data manipulation and export procedures; 3) automated export procedures for 
seamless data downloads to common statistical packages; and 4) procedures for import-
ing data from external sources.41  
Data abstracted from the departmental database included demographic data, diag-
nostic biopsy data, symptoms at time of diagnosis, family history, comorbidities, initial 
serology, and anthropometrics. Medical records compiled from PowerChart (Cerner, 
Kansas City, MO) were used to confirm demographic data accuracy with the internal da-
tabase as well as to gather additional information regarding follow-up care.  
Data abstracted from patient medical records included dates of all visits with gas-
troenterologists and registered dietitians were collected. Only the most recent visit date 
for providers in other departments at BCH were recorded. Active medical conditions, 
most recent medications on file, and anthropometric data from follow-up visits were 
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recorded. Additional family history gathered included the presence of absence of celiac 
disease in the immediate household, with attempts to distinguish between siblings and 
adults. Laboratory tests including celiac serologies, hepatitis B titers, hemoglobin, hema-
tocrit and vitamin D levels. In depth visit information was collected for the most recent 
follow-up visit with GI and/or nutrition. This data included clinic location, clinician re-
ported status of gluten free diet adherence, active symptoms at time of visit, and recom-
mended follow-up interval. Most recent insurance provider on file was also recorded. 
To facilitate analysis based on socioeconomic status, relevant census information 
was collected from the U.S. Census Bureau using the last zip code on file and year of last 
visit at any BCH department. Information inferred based on geographic location included 
median income, poverty rates, and percent of district with a high school or college de-
gree. The exception to this was any individual who was seen in the year 2017, in which 
2016 census data was used since at the time of this study the U.S. Census Bureau has not 
released 2017 data. Geographical distance between clinic sites and home zip code were 
determined using the haversine formula with corresponding latitude and longitude coordi-
nates.  
Data Analysis 
Statistical analysis was performed using R42 version 3.2.1 using RStudio43 version 
1.1.383. Pearson’s correlation was used to find associations between continuous variables 
such as age at diagnosis, median income, and time until lost to follow-up. Paired t-tests 
(or Wilcoxon signed rank sum for non-parametric populations) were used to find associa-
tions between continuous and categorial variables, such as age at diagnosis and defined 
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follow-up adherence categories. Other tests used included one-way ANOVA (or Kruskal 
Wallis for non-parametric populations) and Chi-squared tests. The Kaplan-Meier method 
was used to determine rate of loss to follow-up in this cohort. Survival curves were cen-
sored to remove the subject when they reached age 18 or attended a visit after June 1st, 
2016 to account for this study’s time period ending in 2017. Two-sided P-values <0.05 
were considered statistically significant.   
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RESULTS 
Characterization of Cohort 
 Of the 250 subjects included, 9 attended BCH for the sole purpose of obtaining a 
second opinion and thus were excluded from the analysis as per exclusion criteria. Of the 
remaining 241 subjects, 64% were female, median age of diagnosis was 9.70 years, and 
median age at last clinical visit was 12.75 years (Table 1) No subjects were reported as 
deceased during the observation period. Race was unknown or not reported for 37 sub-
jects, and, of the 204 reported, only 11 (5%) were non-Caucasian. Data on household 
composition was available for a majority of the subjects (N=224), indicating that 195 
(87%) subjects had at least two adults in the household. Sibling data was available for 
228 subjects, 114 (50%) had only one sibling and 18 (8%) were an only child. This co-
hort included 4 pairs of siblings. There were only 14 (6%) subjects who had an out of 
state zip code; 8 from New Hampshire, 3 from Rhode Island and 1 each from Connecti-
cut, New Jersey, and New York. However, the median distance from the main hospital 
was 12.3 miles. A median of 95% of adults in the census designated regions had a high 
school diploma or higher, compared to the 2017 national average of 87%.44  
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Table 1: Demographic Information (N=241)  
Female [N (%)] 154 (64%) Single-parent household (N=225) 28 (12%) 
Non-Caucasian 
(N=205) 
11 (5%) Median Income Above $100,000 
[N (%)] 
105 (43%) 
Median Age at 
Diagnosis [IQR] 
9.70  
[6.23,13.33] 
Median Percent Adults  
with HS Diploma 
95% 
Median Age at 
Last Visit [IQR] 
12.75  
[9.27, 16.23] 
Median Distance to  
Hospital (mi) [IQR] 
12.3  
[6.9, 22.5] 
  Medicaid/CHIP as  
Primary Insurance (N=237) 
20 (8%) 
  
 Only one subject had a Marsh score of 1 at diagnosis, with the rest of the cohort 
having a Marsh score of 3. Most subjects had at least one other medical condition in addi-
tion to celiac disease. Only 33% (N=80) subjects had no other medical conditions listed. 
The most frequent coexisting conditions as well as those related to celiac disease are 
listed in Table 2. 
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Table 2: Coexisting Medical Diagnosis by System (N=241) 
Gastrointestinal  Endocrine  
Chronic Constipation 32 (13%) Type I Diabetes Mellitus 21 (9%) 
Gastroesophageal Reflux Disease 12 (5%) Thyroid Disease 9 (4%) 
Eosinophilic Esophagitis 10 (4%) Short Stature 7 (3%) 
Inflammatory Bowel Disease 2 (1%) Osteopenia 4 (2%) 
Irritable Bowel Syndrome 5 (2%) Psychiatric  
Nutrition  ADD/ADHD 21 (9%) 
Growth concerns  6 (2%) Anxiety 9 (4%) 
Eating Disorder 5 (2%) Depression 4 (2%) 
Obesity 4 (2%) Other  
Nutritional Deficiency 2 (1%) Asthma 19 (8%) 
Gynecologic  Scoliosis 9 (4%) 
Endometriosis 4 (2%) Trisomy 21 4 (2%) 
Irregular menses 2 (1%) Iron-Deficiency Anemia 3 (1%) 
 
Family history of celiac disease was present in 81 (36%) subjects1, with 11 (14% 
of subpopulation) of these individuals having both a parent and sibling with celiac dis-
ease. History of a first degree relative having celiac disease resulted in 34 referrals to the 
Celiac Disease Program after screening for autoantibodies was positive. 
At diagnosis, abdominal pain (57%), constipation (34%), weight loss (24%), and 
vomiting or nausea (24%) were the most frequent symptoms (Figure 1) Other symptoms 
included hematochezia, hair loss, and either fecal or urine incontinence. At time of last 
                                                        
1 Family history of celiac disease unknown or not reported in 17 subjects 
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visit, over half of the subjects (61%) had resolution of their original complaint of ab-
dominal pain and 30% of the total cohort reported being asymptomatic compared to only 
6% at presentation. Resolution of symptoms for subjects who did not return for a visit af-
ter diagnosis is unknown and was not considered. 
  
Figure 1: Percentage of cohort with symptoms at time of presentation and alleviation of 
symptoms at time of last clinical visit. Includes subjects presenting with multiple symptoms. 
N= 241 
Visit Information 
The median time between the initial celiac consultation and biopsy date was 23 
[13, 32] days and median time to first follow-up visit was 59 [20, 109] days.  
 19 
Most subjects (83%) attended at least one visit with a dietitian in either a class-
room setting or an individual visit (Table 3). Visiting with a dietitian was not associated 
with a significant difference on assessed dietary adherence at the last clinical visit at-
tended (P>0.26). Family history of celiac disease was also not associated with attending a 
dietitian visit (P=0.13) or assessed dietary adherence at last visit (P=0.17). 
Table 3: Utilization of Dietitian Services 
GFD Adherence at 
Time of Last Clini-
cal Visit 
Attended nutri-
tion class and in-
dividual visit 
(N=74) 
Attended  
nutrition class 
only 
(N=51) 
Attended  
individual visit 
only 
(N=76) 
No RD  
Visits 
(N=40) 
Adherent 62 (84%) 41 (80%) 53 (70%) 27 (68%) 
Non-Adherent 8 (11%) 4 (8%) 11 (14%) 4 (10%) 
Unknown 0 2 (4%) 6 (8%) 1 (2%) 
Lost After Biopsy 4 (5%) 4 (8%) 6 (8%) 8 (20%) 
 
Almost half of subjects were on dietary supplements after diagnosis, with higher 
rates in those with vitamin deficiencies. Of the 179 subjects who had vitamin D levels 
available, 119 (66%) had at least one result indicating vitamin D deficiency. The number 
of subjects who had a low vitamin D level at time of their last documented blood draw 
was reduced to 68 (38%), or 60% of the original subjects identified as vitamin D defi-
cient. These individuals had increased usage of vitamin D supplements (P=0.03). How-
ever, multivitamin usage did not differ significantly (P=0.19). Attendance of a visit with a 
dietitian was not associated with use of a multivitamin or supplement or presence or ab-
sence of vitamin D deficiency. 
 
 20 
Table 4: Utilization of Multivitamin and Vitamin D Supplements 
Supplement Use Entire Cohort 
(N = 241) 
Vitamin D Deficient 
(N = 68) 
Multivitamin 117 (49%) 30 (44%) 
Vitamin D 45 (19%) 22 (32%) 
Multivitamin & Vitamin D 26 (11%) 12 (18%) 
 
 At least one anthropometric measurement was available for the entire cohort. At 
diagnosis, 16 (7%) subjects were underweight, 29 (12%) were overweight, and 4 (2%) 
were obese. For those who attended at least one follow-up visit with the GI and Nutrition 
Department and had measurements available (N=227), 6 (3%) were underweight, 22 
(15%) were overweight, and 4 (2%) were obese at time of last follow-up visit. Of those 
who were underweight at time of diagnosis, only 2 were also classified as underweight at 
time of last follow-up visit, with both visits greater than one year after initial diagnosis.  
Over half of the subjects (62%) who were overweight or obese at time of diagnosis were 
also overweight or obese at time of last follow-up visit. The median time since diagnosis 
for individuals who were overweight or obese at last follow-up visit was 34.2 months 
[21.0, 53.4]. Across the entire cohort, height and weight steadily increased compared to 
baseline measurements taken at diagnosis (Figure 2) with the most significant growth oc-
curring at least 2 years after diagnosis.   
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Figure 2: Top) Changes in Z-score of height measurements compared to Z-score of height at 
diagnosis. Total of 932 measurements compared over 7 years. N = 228. Bottom) Changes in 
Z-score of weight measurements compared to Z-score of weight at diagnosis. Total of 932 
measurements compared over 7 years. N = 232.  
ns (p>0.05), ** (p<0.01), *** (p<0.001), **** (p<0.0001) 
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Final celiac antibody serologies were available for 141 (59%) subjects, with one 
quarter of this subgroup (N=35) having an tTG IgA titer above the upper limit of normal 
with a median time since diagnosis of 20 months [12.4, 28.6]. Subjects who continued to 
follow-up with GI until the end of the study period were significantly more likely to have 
normalized serology levels regardless of how strict this adherence to follow-up visits 
were (Figure 3). After being lost to GI, 10 (4%) subjects continued to have celiac serolo-
gies ordered by other department providers, with 2 having an abnormal tTG IgA over 3 
years after initial diagnosis. These two individuals were lost to GI within one year.  
 
Figure 3: Results of tTG IgA serologies at last clinical GI visit based on adherence to follow-
up. Dotted line represents upper limit of normal. N = 146. ns (p>0.05), ** (p<0.01), **** 
(p<0.0001) 
Hepatitis B titers were ordered for 106 (44%) subjects seen for follow-up, and of 
these individuals, 87 (82%) were not immune to the virus. Of this subgroup of non-
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immune subjects, 40 (46%) had repeat titers documented with 30 being immune and 10 
remaining negative for the hepatitis B surface antibody. There were no hepatitis B anti-
body titers ordered prior to August 2013. 
 
Adherence to Follow-Up Analysis 
 
Overall, 50% of subjects were lost to follow-up within 39 months of diagnosis 
with the largest decrease occurring during the first 12 months (Figure <<>>). By 5 years 
post-diagnosis, almost 75% of subjects were no longer attending follow-up visits. There 
were 22 (9%) subjects who did not attend a clinical GI visit after diagnostic endoscopy, 
14 (64%) of whom attended at least one visit with a dietitian after diagnosis (Table 5).  
An additional 37 (15%) subjects were lost within the first year after diagnosis, with more 
than half lost within the first six months (N=20). Individuals who were eligible to transfer 
care to an adult gastroenterologist comprised 14% (N=34) of the entire cohort population. 
Half of these individuals did not return for follow-up while the other half continued to see 
their pediatric gastroenterologist until the end of the observation period. Those who con-
tinued to be seen by their pediatric celiac care provider after the age of 18 were more 
likely to have been diagnosed at an earlier age compared to those who left BCH care after 
turning 18 (P<0.01).  
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Table 5: Categorization of Subject Adherence to Recommended Follow-Up  
Category N (%) 
1a: Lost after biopsy, did not attend education with dietitian 
1b: Lost after biopsy, attended education with dietitian 
8 (3) 
14 (6) 
2: Lost within first year, attended at least one follow-up visit 37 (15) 
3: Lost after first year, attended at least one visit within and after first year  61 (25) 
4: Following up, non-adherent to recommended follow-up schedule (first visit af-
ter 12 months and/or follow-up visits over 16 months apart) 
63 (26) 
5: Following up, adherent to recommended schedule  41 (17) 
6: Lost to follow-up after age 18 17 (7) 
 
Figure 4: Kaplan-Meier estimator analysis curve of 241 subjects from diagnosis until lost to 
follow-up. * indicates censor when subject turned 18 years of age or end of study time pe-
riod. 
 25 
Almost half of the cohort (N=105, 43%) had a zip code in a census designated re-
gion in which the median income was over $100,000. Of those lost within the first year 
after diagnosis, including those lost after biopsy, less than one quarter were from this 
high-income subgroup (24%). One in three subjects (N=45) from the lower income group 
(N=136) were lost within this time frame. Subjects with Medicaid listed as their last in-
surance provider on file (N=20) had a shorter median duration of follow-up adherence 
compared to those who used private insurance providers (P=<0.01), with 50% of this sub-
group being lost to follow-up within one year. 
Subjects who were lost to follow-up within one year had a median age of diagno-
sis of 11.4 years compared to age of diagnosis, 8.7 years, of those who were adherent to 
follow-up for at least one year (P=0.03). Having a sibling with celiac disease resulted in a 
shorter duration of follow-up adherence compared to those who did not have a sibling 
with celiac disease, even when controlling for other family members with celiac disease 
(P=0.01). Of the 4 pairs of siblings in this cohort, only 1 sibling pair was considered ad-
herent to follow-up; 1 was lost after diagnosis, 1 within the first year, and the final pair 
was lost to follow-up after 26 months. Individuals who were asymptomatic at last visit 
also had decreased adherence to follow-up compared to those who continued to have ce-
liac disease symptoms (P=0.02). 
Almost three quarters (73%) of subjects had at least one visit with a non-GI pro-
vider within the BCH network. Attending visits with non-GI providers within the BCH 
network was not associated with adherence to GI follow-up (P=0.77). Over 20% of the 
entire cohort attended a visit with a non-GI provider after being lost to GI, thus 
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confirming that these individuals were not lost due to relocation. Of those lost within one 
year after diagnosis, including those lost immediately after biopsy, 26 (44%) met the cri-
teria for confirmation of residency and thus relocation was not the reason for not attend-
ing follow-up. 
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DISCUSSION 
 
 In this retrospective cohort study of children with a biopsy-confirmed diagnosis of 
celiac disease, the principal finding was that most were non-adherent to recommended 
follow-up care with 50% of individuals being lost to both gastroenterology and nutrition 
follow-up within 3 years of diagnosis. The sharpest drop in follow-up adherence occurred 
during the first year after diagnosis, with 25% of subjects being lost to follow-up within 
this time frame. Children diagnosed at a younger age were more adherent to follow-up 
compared to those diagnosed during adolescence. However, those who had siblings with 
celiac disease were less adherent to follow-up compared to those who had no family his-
tory or remote family history of celiac disease. Socioeconomic disparities also existed be-
tween those with public and private health insurance, with individuals on Medicaid hav-
ing decreased follow-up adherence.  
 These numbers are disconcerting because successful treatment of celiac disease is 
dependent on adequate patient knowledge and implementation of dietary and lifestyle 
modifications. A 2015 study demonstrated that continual follow-up and dietary education 
is associated with increased adherence to a gluten-free diet as well as better quality of 
life. Counseling by a dietitian was shown to result in better understanding of the gluten-
free diet in recently diagnosed individuals compared to those who did not attend a visit 
with a dietitian.45 Thus, in this current study, with 40 (17%) subjects failing to attend a 
visit with a registered dietitian, it is questionable whether this subpopulation was properly 
 28 
educated on accurate information regarding a gluten-free diet, especially the 8 subjects 
who did not meet with either a dietitian or GI clinician after diagnosis.  
Over 20% of subjects who had an abnormal celiac antibody level did not return 
for repeat serologies. In addition, over half of these individuals were diagnosed over 18 
months prior to the drawn labs. Results above the upper limit of normal after the first 18 
months of diagnosis may be indicative of poor intestinal recovery and/or continual gluten 
exposure.46 Ergo, it’s uncertain if the potential source of gluten exposure was identified 
in these individuals because they did not have a subsequent visit with GI or nutrition. 
 Less than half of this cohort had a documented hepatitis B serology. Individuals 
who were lost to follow-up before this test was routinely ordered are at risk due to the 
fact that their immunization status is unknown. If their status reflects the subpopulation of 
subjects whose status was checked, then most of these individuals are most likely not im-
mune to hepatitis B. Lack of adherence to follow-up results in individuals being at risk 
for hepatitis B infection. 
 Continued follow-up care and adherence to the gluten-free diet resulted in a ma-
jority of these subjects having an increase in height and weight percentiles. Over 75% of 
those who were underweight at time of diagnosis had their growth increase and normalize 
after diagnosis and follow-up. However, 15% of the cohort was considered overweight or 
obese at the time of their last follow-up. This is consistent with findings in other studies 
regarding the tendency of the GFD to cause excessive weight gain as well as the im-
portance of follow-up to evaluate nutritional status.47,48 Besides assuring adequate growth 
after commencing a GFD, continual dietitian guidance along with clinician monitoring 
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can help children form healthy dietary habits that will benefit their long-term wellness. 
Studies have shown that children with chronic illnesses that focus restricting food intake 
have an increased risk for developing an eating disorder and higher incidences of psycho-
logical problems such as anxiety and depression.49,50 This is consistent with the current 
study as 2% of the cohort had an eating disorder, 4% had anxiety, and 2% had depres-
sion. Services offered by BCH to help families adjust to the lifestyle and dietary changes 
required after diagnosis include trained celiac social workers, psychological services, and 
family support groups. Regular follow-up visits with the celiac care team can help chil-
dren and family members identify problems early and provide appropriate care for chil-
dren who have difficulties adapting to the GFD after diagnosis.  
One of the aims of this study was to identify factors that may be associated with 
nonadherence to follow-up. Subjects who were asymptomatic were less likely to attend a 
subsequent follow-up visits compared to those who continued to have celiac symptoms. 
As well as the high rates of dropout within the first year after diagnosis, the second larg-
est decrease in follow-up was between the second and third year after diagnosis. This 
group would have returned for at least one annual visit and met with a dietitian. After this 
time, subjects and their caregivers may feel that they have fully adjusted to their celiac 
disease diagnosis and transition to a gluten-free diet, thus preferring to self-manage their 
condition.  
Children diagnosed at a younger age were more likely to be adherent to recom-
mended follow-up compared to those who were diagnosed in adolescence. The decrease 
in follow-up adherence in older children has been demonstrated in prior studies, as well 
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as the association between lack of GFD adherence in children lost to follow-up.51 Contin-
ual follow-up throughout childhood is important, especially throughout different stages of 
development.  A recent study, also conducted at BCH, surveyed children with celiac dis-
ease, and their caretakers, and aimed to evaluate self-management competencies across 
multiple age groups. Key findings included that, as children progress through adoles-
cence, new situations arose that required additional skills and understanding of how to 
maintain a gluten-free diet.52 Another similar study indicated that adolescents and young 
adults face challenges maintaining a GFD when relying on school cafeterias and dining 
services for the majority of their meals.53 By neglecting to continue with regular follow-
up visits with their celiac provider, children with celiac disease and their families are thus 
unable to receive adequate and updated information about navigating the intricacies of a 
GFD in these new situations.  
In this study, subjects who had turned 18 made up of a unique subpopulation, as 
discontinuing follow-up at BCH was not classified as being lost. Subjects who had turned 
18 had a 50% chance of continuing care with their pediatric provider. While one would 
like to believe that the other 50% successfully transferred their care to an adult gastroen-
terologist, prior studies on individuals with chronic illnesses diagnosed during childhood 
have shown that this transition is not always successfully made.54 In this cohort, subjects 
who were diagnosed at a younger age were more likely to continue care with their pediat-
ric GI past the age of 18. This may be due to comfort and familiarity with their provider 
developed over the years.   
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Socioeconomic circumstances were also associated with decreased adherence to 
follow-up. Prior studies have identified socioeconomic disparities in individuals with ce-
liac disease. In those with a lower socioeconomic status, celiac disease is often underdi-
agnosed, although these individuals often report more severe symptoms which take 
longer to resolve compared to the rest of the celiac disease population.37 The increase in 
food costs associated with a GFD is often cited as a barrier to treatment and can be espe-
cially pronounced in populations who already have difficulties securing meals.5  
 A 2012 study that focused on follow-up adherence in children with congenital 
heart disease also found that increased cancelled visits and lower median income were as-
sociated nonadherence to follow-up. This study was conducted in Canada, a country with 
access to universal healthcare, indicated that median income is not only attributed to ac-
cess to health insurance but also factors such as caregiver ability to take time off of work 
to attend visits during business hours as well as associated transportation costs.55  
Children with siblings with celiac disease were less likely to be adherent to fol-
low-up compared to those who either had no family history or had distant family history 
of celiac disease. The increased time commitment by caregivers to attend additional visits 
for these children may influence their adherence to clinical follow-up or may feel that 
they understand the complexities of the GFD.   
Limitations of this study include a homogenous sample size limited to children 
with means of access to a tertiary care center. Missing information from medical records 
due to conversion of paper charts to electronic versions resulted in some data gaps in sub-
ject records, but this was mostly concentrated to encounters in early 2010. Other missing 
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information included serological results or other data not being entered into the BCH 
medical records from offices outside of the network. The cohort of subjects sampled for 
this project included only children with a diagnosis of celiac disease confirmed through 
intestinal biopsy. It is possible that children diagnosed without biopsy would have differ-
ent patterns of adherence to follow-up, although the number of individuals diagnosed 
without biopsy confirmation at Boston Children’s Hospital during this time period is lim-
ited.   
Future directions include increasing the population size and expanding to multiple 
centers or settings to increase diversity of the cohort. The sample in this study were 
mostly from more affluent areas of Massachusetts with abundant access to medical facili-
ties. At least one subject was noted to be transferring their care to a primary care provider 
outside of the network. While it is recommended that individuals with celiac disease be 
followed by a gastroenterologist, expanding the study to more underserved areas, where 
access to pediatric gastroenterologists and dietitians is less feasible, could allow for a dif-
fering investigation of follow-up adherence.  
Taking a more interactive approach to determining reasons as to why individuals 
are lost to follow-up could be introduced by contacting these children and their families 
and investigating specific reasons for not returning for follow-up. The limitations of this 
approach however would be the fact that many of the contact information in the medical 
records of these individuals may be outdated.   
In conclusion, the present study illustrates that children with celiac disease are not 
being followed-up adequately. Identifiable disparities in follow-up adherence exist in the 
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pediatric celiac disease population. Factors associated with non-adherence include Medi-
caid as the primary health insurer, older age at diagnosis, and siblings with celiac disease. 
Future studies should be focused on emphasizing the importance of continuity of follow-
up care to both providers and patients as well as exploring proactive measures to increase 
adherence in children with identified risk factors.  
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